Cambridge, MA · Founded 2017 · Privately Held (backing)
Developer of a wearable microfluidic sensor technology designed to improve health and drive athletic performance. Epicore Biosystems is based in Cambridge, MA and was founded in 2017. It was valued at $121 million at its later-stage round in May 2025, the last priced event on record. It has raised $43.1 million across 4 recorded rounds; the latest was a $25.7 million early-stage round in Dec 2024.
PMV mark · valuation
$121.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$43.1M
Last round
Early Stage VC
Dec 2024
Cap table — not yet on record
Epicore Biosystems's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Epicore Biosystems with a free account
·The complete investor list: 13 names
·Watch Epicore Biosystems: the Monday email on marks, rounds and moves
Where does Epicore Biosystems's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Epicore Biosystems's 4 recorded funding rounds.
